Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation

Scottish retrospective observational longitudinal cohort study (n=45) found tezacaftor-ivacaftor improved BMI and reduced days in hospital and days receiving antibiotics, however there was no significant improvement in % predicted FEV1.

European Journal of Hospital Pharmacy